GoLYTELY and Pregnancy
The FDA has given a pregnancy Category C rating to GoLYTELY (polyethylene glycol electrolyte solution). Pregnancy studies on this medication are lacking, so the drug's risks are still unknown. However, serious problems are unlikely, as GoLYTELY is not expected to be absorbed into the blood. Your healthcare provider may prescribe this laxative during pregnancy if the benefits outweigh the risks.
GoLYTELY® (polyethylene glycol electrolyte solution) is a prescription laxative used for bowel preparation before certain intestinal procedures. Specifically, it is used to empty the bowel prior to a colonoscopy or barium enema x-ray examination. It is unknown if GoLYTELY is safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies.
In addition, medicines that have not been adequately studied in pregnant women or animals are automatically given a pregnancy Category C rating.
GoLYTELY has not been studied in pregnant animals or women. This medication is not expected to be absorbed into the blood, so it would likely not be harmful to a developing fetus. However, because of the lack of studies on GoLYTELY use in pregnancy, all potential risks cannot be ruled out.
In general, a pregnancy Category C medicine should be given to a pregnant woman only if the healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child. If you require bowel preparation before an intestinal procedure during pregnancy, your healthcare provider may recommend GoLYTELY if safer alternatives are not available.